Drug Type Herbal medicine |
Synonyms LY-02404, LY02404, Lipascor |
Target |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (08 Dec 1996), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperlipidemias | CN | 08 Dec 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Primary Hyperlipidemia | Phase 2 | CN | 24 Dec 2019 | |
Lipid Metabolism Disorders | Phase 1 | US | 01 Nov 2015 |
Not Applicable | - | 8,503 | qckfblfxca(ymgflnqiic): OR = 0.94 (95% CI, 0.53 - 1.65) View more | - | 01 Sep 2019 | ||
Phase 4 | 60 | (Simvastatin) | duzaikwcxl(nsswhgttsq) = vbhkqbtrir qadqvvtcig (tpiigiqtsn, cfzukmuqnh - qnsjkesdhc) View more | - | 19 May 2014 | ||
(XueZhiKang) | duzaikwcxl(nsswhgttsq) = ojzavipafi qadqvvtcig (tpiigiqtsn, jtxdmfpcpw - ywwdwdbgso) View more |